These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 1385560)
1. Epitope mapping of the human biliary amphipathic, anionic polypeptide: similarity with a calcium-binding protein isolated from gallstones and bile, and immunologic cross-reactivity with apolipoprotein A-I. Domingo N; Grosclaude J; Bekaert ED; Mège D; Chapman MJ; Shimizu S; Ayrault-Jarrier M; Ostrow JD; Lafont H J Lipid Res; 1992 Oct; 33(10):1419-30. PubMed ID: 1385560 [TBL] [Abstract][Full Text] [Related]
2. APF/CBP, the small, amphipathic, anionic protein(s) in bile and gallstones, consists of lipid-binding and calcium-binding forms. Lafont H; Domingo N; Groen A; Kaler EW; Lee SP; Koehler R; Ostrow JD; Veis A Hepatology; 1997 May; 25(5):1054-63. PubMed ID: 9141417 [TBL] [Abstract][Full Text] [Related]
3. Biliary anionic peptide fraction/calcium binding protein inhibits apolipoprotein A-I-mediated cholesterol efflux from cultured cells. van Wijland MJ; de Waart DR; Groen AK Biochem Biophys Res Commun; 2001 Sep; 287(1):1-4. PubMed ID: 11549244 [TBL] [Abstract][Full Text] [Related]
4. Modulating effects of bile salt hydrophobicity on bile secretion of the major protein of the bile lipoprotein complex. Domingo N; Chanussot F; Botta D; Reynier MO; Crotte C; Hauton J; Lafont H Lipids; 1993 Oct; 28(10):883-7. PubMed ID: 8246688 [TBL] [Abstract][Full Text] [Related]
5. The amphipathic alpha-helical repeats of apolipoprotein A-I are responsible for binding of high density lipoproteins to HepG2 cells. Leblond L; Marcel YL J Biol Chem; 1991 Apr; 266(10):6058-67. PubMed ID: 1706710 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies as probes of high-density lipoprotein structure: identification and localization of a lipid-dependent epitope. Silberman SR; Bernini F; Sparrow JT; Gotto AM; Smith LC Biochemistry; 1987 Sep; 26(18):5833-43. PubMed ID: 2445375 [TBL] [Abstract][Full Text] [Related]
7. Expression of human apolipoprotein A-I epitopes in high density lipoproteins and in serum. Marcel YL; Jewer D; Vézina C; Milthorp P; Weech PK J Lipid Res; 1987 Jul; 28(7):768-77. PubMed ID: 2442276 [TBL] [Abstract][Full Text] [Related]
8. The thyroxine-binding site of human apolipoprotein-A-I: location in the N-terminal domain. Benvenga S; Cahnmann HJ; Robbins J Endocrinology; 1991 Jan; 128(1):547-52. PubMed ID: 1702705 [TBL] [Abstract][Full Text] [Related]
9. Evidence for the presence of lipid-free monomolecular apolipoprotein A-1 in plasma. Miyazaki O; Ogihara J; Fukamachi I; Kasumi T J Lipid Res; 2014 Feb; 55(2):214-25. PubMed ID: 24304668 [TBL] [Abstract][Full Text] [Related]
10. Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase. Implications for HDL function. Lee M; Uboldi P; Giudice D; Catapano AL; Kovanen PT J Lipid Res; 2000 Jun; 41(6):975-84. PubMed ID: 10828090 [TBL] [Abstract][Full Text] [Related]
11. Epitope mapping of apolipoprotein A-I using endoproteinase cleavage and monoclonal antibodies in an enzyme-linked immunosorbent assay. Allan CM; Tetaz T; Fidge NH J Lipid Res; 1991 Apr; 32(4):595-601. PubMed ID: 1713244 [TBL] [Abstract][Full Text] [Related]
12. Immunochemical Approach for Monitoring of Structural Transition of ApoA-I upon HDL Formation Using Novel Monoclonal Antibodies. Kimura H; Mikawa S; Mizuguchi C; Horie Y; Morita I; Oyama H; Ohgita T; Nishitsuji K; Takeuchi A; Lund-Katz S; Akaji K; Kobayashi N; Saito H Sci Rep; 2017 Jun; 7(1):2988. PubMed ID: 28592796 [TBL] [Abstract][Full Text] [Related]
13. Influence of dehydrocholic and cholic acids on the biliary secretion of anionic polypeptide fraction, the major apoprotein of the biliary lipoprotein complex. Chanussot F; Domingo N; Tuchweber B; Lafont H; Yousef I Scand J Gastroenterol; 1992; 27(3):238-42. PubMed ID: 1502488 [TBL] [Abstract][Full Text] [Related]
14. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles. Sviridov D; Pyle L; Fidge N Biochemistry; 1996 Jan; 35(1):189-96. PubMed ID: 8555173 [TBL] [Abstract][Full Text] [Related]
15. Measurement of apolipoprotein A1 in cholesterol gallstones and gallbladder bile of patients with gallstones. Hasegawa T; Makino I J Gastroenterol; 1995 Feb; 30(1):96-102. PubMed ID: 7719423 [TBL] [Abstract][Full Text] [Related]
16. Evolution of mammalian apolipoprotein A-I and conservation of antigenicity: correlation with primary and secondary structure. Collet X; Marcel YL; Tremblay N; Lazure C; Milne RW; Perret B; Weech PK J Lipid Res; 1997 Apr; 38(4):634-44. PubMed ID: 9144079 [TBL] [Abstract][Full Text] [Related]
17. Antibodies to the carboxyl terminus of human apolipoprotein A-I. The putative cellular binding domain of high density lipoprotein 3 and carboxyl-terminal structural homology between apolipoproteins A-I and A-II. Allan CM; Fidge NH; Kanellos J J Biol Chem; 1992 Jul; 267(19):13257-61. PubMed ID: 1377682 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of apolipoprotein E epitope expression on human lipoproteins: importance for apolipoprotein E function. Krul ES; Tikkanen MJ; Schonfeld G J Lipid Res; 1988 Oct; 29(10):1309-25. PubMed ID: 2466929 [TBL] [Abstract][Full Text] [Related]
19. Characterization of monoclonal antibodies against apolipoproteins A-I and A-II. Epitope expression in LpA-I and LpA-I:A-II particles. Ulloa N; Bustos P; Castro G; Fruchart J; Vera M; Fruchart JC; Calvo C Hybridoma; 1999 Dec; 18(6):513-20. PubMed ID: 10626680 [TBL] [Abstract][Full Text] [Related]
20. Localization of an apolipoprotein A-I epitope critical for activation of lecithin-cholesterol acyltransferase. Banka CL; Bonnet DJ; Black AS; Smith RS; Curtiss LK J Biol Chem; 1991 Dec; 266(35):23886-92. PubMed ID: 1721059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]